Pfizer/BioNTech Covid-19 Vaccine

Despite infecting more than 50 million people worldwide and causing nearly 1.3 million deaths, vaccine studies developed against the coronavirus (Covid-19) pandemic are nearing completion. The Pfizer/BioNTech vaccine, announced to be more than 90% effective against Covid-19, is preparing for distribution, and it is reported that hundreds of thousands of doses have been produced since the summer. Planned to be distributed to critically ill individuals in the UK and USA before the end of the year, photos showing the entire process from the production line to shipment highlight the great effort put into developing and mass-producing a new vaccine.